Determination of the Relative Toxicity of Amphotericin B Formulations: A Red Blood Cell Potassium Release Assay
| Autor: | C. G. S. Eley, C. R. Skenes, A. Satorius, T. H. Bunch, G. M. Jensen, C. A. Weissman, N. Amirghahari, K. L. Moynihan |
|---|---|
| Rok vydání: | 1999 |
| Předmět: |
Drug
Liposome media_common.quotation_subject Potassium Pharmaceutical Science chemistry.chemical_element General Medicine Biology Pharmacology bacterial infections and mycoses Red blood cell medicine.anatomical_structure Parenteral nutrition chemistry Amphotericin B Toxicity medicine Incubation medicine.drug media_common |
| Zdroj: | Drug Delivery. 6:81-88 |
| ISSN: | 1521-0464 1071-7544 |
| Popis: | Amphotericin B remains the drug of choice for the treatment of life-threatening, systemic fungal infections. Nevertheless, the use of amphotericin B in the traditional deoxycholate formulation (d-AmB) is limited by severe toxic side effects. Several relatively new formulations have recently received regulatory approval: amphotericin B colloidal dispersion (ABCD), amphotericin B lipid complex (ABLC), and liposomal amphotericin B (AmBisome). We quantitate the level of reduction of intrinsic toxicity of these formulations over d-AmB using a red blood cell potassium release assay, employing a variety of blood sources and incubation times. We also examine the practice of diluting d-AmB in the parenteral nutrition product Intralipid. Overall, the propensity in each formulation of amphotericin B to partition into the red cell membrane during incubation is measured by determining the concentration of amphotericin B required to achieve 50% potassium release. The concentrations leading to 50% potassium release were... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|